HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) All Versions of this Article: thx.2006.066670v1 thx.2006.066670v2 62/6/475    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Qiu, Y. Articles by Jeffery, P. K Search for Related Content PubMed PubMed Citation Articles by Qiu, Y. Articles by Jeffery, P. K Topic Collections Editor's choice Relevant Articles

Bronchial mucosal inflammation and upregulation of CXC chemoattractants and receptors in severe exacerbations of asthma

¹ Lung Pathology, Department of Gene Therapy, Imperial College, Royal Brompton Hospital, London, UK
² Department of Medicine, Baylor College of Medicine, Ben Taub General Hospital, Houston, Texas, USA

Correspondence to:
Correspondence to:
Professor Peter K Jeffery
Lung Pathology, Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK; p.jeffery{at}ic.ac.uk

Background: A study was undertaken to test the hypothesis that severe exacerbations of asthma are characterised by increased bronchial mucosal neutrophilia associated with upregulation of neutrophil chemoattractant ligands and their specific cell surface receptors.

Methods: Immunohistology and in situ hybridisation were applied to endobronchial biopsy specimens from three groups: (1) 15 patients admitted to hospital with a severe exacerbation of asthma (E-asthma), (2) 15 with stable asthma (S-asthma) and (3) 15 non-atopic and non-smoker surgical controls (NSC).

Results: There were significantly more neutrophils and eosinophils in the epithelium and subepithelium of patients in the E-asthma group (median (range) neutrophils 7 (0–380) and 78 (10–898)/mm², eosinophils 31 (0–167) and 60 (6–351)/mm², p0.01 compared with NSC: 0 (0–10, 0–7, 0–18 and 0–3)/mm², respectively), resulting in similar final densities of eosinophils and neutrophils. With respect to neutrophil chemoattractants and receptors, counts of CXCL5, CXCL8, CXCR1 and CXCR2 mRNA-positive cells in the subepithelium of the E-asthma group were, respectively, 5, 4, 4 and 18 times greater (p0.01) than those of the NSC group. In the E-asthma group, cells expressing CXCL5 or CXCR2 were eightfold and threefold more frequent than those expressing CXCL8 or CXCR1 mRNA, respectively (p<0.01). CXCL5 and CXCR2 in E-asthma were associated with the number of eosinophils (r = 0.59 and 0.66, p<0.02 for both) rather than the number of neutrophils.

Conclusion: In severe exacerbations of asthma there is a bronchial mucosal neutrophilia, eosinophilia and upregulation of CXC chemoattractants and their receptors. CXCL5 and CXCR2 have an association with eosinophila only, and these represent potentially new targets for treatment in exacerbations of asthma.

Abbreviations: COPD, chronic obstructive pulmonary disease; EG2, anti-eosinophil cationic protein; FEV₁, forced expiratory volume in 1 s; FVC, forced vital capacity; NE, neutrophil elastase; RBM, reticular basement membrane

Relevant Articles

The laws of attraction: chemokines, neutrophils and eosinophils in severe exacerbations of asthma

Graziella Turato, Simonetta Baraldo, Renzo Zuin, and Marina Saetta
Thorax 2007 62: 465-466. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				I. M. Adcock and P. J. Barnes Molecular Mechanisms of Corticosteroid Resistance Chest, August 1, 2008; 134(2): 394 - 401. [Abstract] [Full Text] [PDF]